insights_auto
Why is CGEM up 6,74%?
Dive Deeperchevron_right
CGEM:NASDAQ
Cullinan Therapeutics Inc
15,51 $
arrow_upward
+6,74%(+0,98) 1D
15,51 $
0,00% (0,00)
bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CGEM...
Open
14,76 $
High
15,56 $
Low
14,59 $
Mkt. cap
998,14 մլն
Avg. vol.
1,07 մլն
Volume
1,16 մլն
52-wk high
23,19 $
52-wk low
5,68 $
EPS
-3,41 $
Beta
-0,05
Shares outstanding
64,36 մլն
No. of employees
109
Open
14,76 $
High
15,56 $
Low
14,59 $
Mkt. cap
998,14 մլն
Avg. vol.
1,07 մլն
Volume
1,16 մլն
52-wk high
23,19 $
52-wk low
5,68 $
EPS
-3,41 $
Beta
-0,05
Shares outstanding
64,36 մլն
No. of employees
109
News stories
From web sources and news partners
Investing.com
·
2 օր առաջ
H.C. Wainwright reiterates Cullinan Oncology stock rating on NDA filing
GuruFocus
·
2 օր առաջ
CGEM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $35
TipRanks
·
2 օր առաջ
Cullinan Management Advances NDA for Zipalertinib Combination
Investing.com Canada
·
2 օր առաջ
Form 8K Cullinan Therapeutics, Inc For: 2 October By Investing.com
About Cullinan Therapeutics Inc